Australia Allows Industry Collaboration To Continue

GBMA And Medicines Australia Get One-Year Extension From ACCC

Australia’s competition authority has extended the arrangements allowing local off-patent industry body the GBMA to closely collaborate with brand organization Medicines Australia to co-ordinate supply against the backdrop of the ongoing COVID-19 pandemic.

Handshake
The ACCC has authorized a continuing industry collaboration • Source: Shutterstock

More from Regulation

More from Policy & Regulation